Literature Archives

The LIONS PREY model demonstrated superior accuracy (AUC 0.94) in predicting malignancy for high-risk pulmonary lesions compared to the Herder and Brock models, supporting its clinical use for patients undergoing navigational bronchoscopy.

The randomized controlled trial involved 126 patients, finding that while using a second needle speeds up individual passes (56.2 vs. 82.1 seconds), it did not significantly reduce the overall total procedure time.

Essential reading for interpreting clinical trial data regarding the performance of new bronchoscopic diagnostic tools.

A negative EBUS is not a definitive "all-clear"—with a 10-15% upstaging rate, high-risk tumors still demand strict systematic sampling in the bronch suite and comprehensive lymph node dissection in the OR.

robotic-assisted bronchoscopic cryoablation for pulmonary nodules achieved 100% technical feasibility with a favorable safety profile.

Cryobiopsy demonstrated lower sensitivity (54.5%) for mycobacterial culture compared to forceps biopsy (62.7%) in diagnosing TB pleurisy. Consequently, cryobiopsy is not recommended as a replacement for standard forceps biopsy for this purpose.

Clinicians can confidently offer ELVR to patients across a wider range of BMI categories.

If successful, this trial could establish the erector spinae plane block as a standard pre-procedural adjunct in the interventional pulmonology suite, shifting practice toward multimodal regional anesthesia. Because this is a study protocol, no numerical results, P values, or confidence intervals are yet available.

Demonstrates a novel, minimally invasive approach for treating peripheral lung nodules, expanding the scope of interventional pulmonology beyond biopsy.

Robotic platforms are increasingly capable of complex, multi-site sampling, potentially reducing the need for repeat procedures.

Sequential bilateral BLVR may be a viable strategy for patients who remain symptomatic after a primary unilateral or staged procedure.

An EBUS-based SVM machine learning model combining radiomics and clinical data shows high accuracy (AUC >0.9) in differentiating pulmonary sarcoidosis from mediastinal tuberculosis